Desert King

🌱 Desert King® Leading The Way In Sustainable Saponin Solutions🌱 At Desert King®, we’re proud to be a global company with roots in the United States, Chile, and Mexico, dedicated to harnessing the power of nature to deliver scientific solutions. Using natural components from Quillaja, Yucca, and Jojoba, our products are crafted sustainably, ensuring harmony with the environment. 🔬 Experience Our journey began 45 years ago with a mission to unlock the potential of natural resources. Over the last 25 years, we've made significant advances, particularly in sustainable extraction and innovative applications of Quillaja saponins, benefiting both industries and humanity. 🏆 Leadership Today, Desert King® stands as the global leader and the world’s largest producer of Quillaja saponin-based products. Through responsible sourcing, efficient processing, and reliable delivery, we remain committed to setting the standard in this field. Let’s keep shaping a future where science and nature work together for the betterment of our planet! 🌍✨ #QS21 #Quillaja #DesertKing #Saponins #Sustainability #Innovation #Vaccinesadjuvants

🌿 Desert King’s Role in the Fight Against Malaria – At an Accessible Cost   Desert King’s saponin-based adjuvant is a key ingredient in the revolutionary R21/Matrix-M malaria vaccine, developed by the University of Oxford and the Serum Institute of India. This vaccine utilizes Novavax's Matrix-M adjuvant, which includes Desert King’s sustainably sourced saponins.   With plans to produce 50 to 60 million doses annually over the next three years, the R21/Matrix-M vaccine will bring affordable malaria protection to millions across Africa, with each dose priced under $4.   Malaria remains a major global health threat, causing nearly 600,000 deaths each year. Recently named one of TIME’s Best Inventions of 2024 in the Social Good category, the R21/Matrix-M vaccine is a true game-changer, bringing high-impact prevention to communities most affected by this disease.   At Desert King, we are proud to contribute our Quillaja saponins to five globally approved vaccines for diseases such as COVID-19, shingles, RSV, and malaria. With over 45 years of expertise in responsibly harvesting, processing, and delivering Quillaja-based products, we’re committed to supporting life-saving health solutions worldwide.   #QS21 #Saponins #MalariaVaccine #DesertKing #Sustainable #AffordableHealthcare

🌍💉 A Breakthrough in the Fight Against Malaria at an Accessible Cost Malaria continues to be a significant global health threat, causing nearly 600,000 deaths each year. In response, World Health Organization (WHO) has recommended two vaccines, including the promising R21/Matrix-M, developed by University of Oxford and Serum Institute of India Pvt. Ltd. This vaccine is not only highly effective but also affordable, priced under $4 per dose, making it accessible for millions in Africa. The R21/Matrix-M malaria vaccine, which targets the malaria antigen R21 and includes Novavax's unique Matrix-M adjuvant, has been named "A Game-Changing Vaccine" as part of TIME’s Best Inventions of 2024 in the Social Good category. Serum Institute plans to distribute between 50 and 60 million doses annually over the next three years, contributing to the fight against this deadly disease. At Desert King, we are proud to collaborate with Novavax in the development of this adjuvant, reinforcing our commitment to high innovation and accessibility in health solutions. This milestone, recognized by TIME, marks a significant step towards a healthier and more equitable future. 🔗 Explore More: https://shorturl.at/f9d8D #DesertKing #Novavax #HealthInnovation #Malaria #Vaccines #GlobalHealth #Accessibility #TIMEBestInventions

🌍 Desert King at the World Vaccine Congress Europe 2024 🌍 Desert King had the opportunity to pasticipate as an exhibitor at The World Vaccine Congress Europe, the world's largest pharmaceutical fair, held in Barcelona, Spain. At our booth, we showcased our saponin-based vaccine adjuvants, which are already used in five globally approved vaccines developed by prestigious laboratories like GSK and Novavax, covering diseases such as COVID-19, malaria, RSV, and shingles. We are also very proud to announce that Rodrigo Otero V.P of Desert King presented “The Source of Saponin Adjuvants: QS-21, Approved, Available, and Abundant.” His presentation highlighted Desert King's commitment to a reliable supply chain and the sustainable sourcing of #QS21, an essential adjuvant for vaccine efficacy. Our team had an extraordinary experience reconnecting with clients and suppliers, expanding our network, and learning about the latest advancements in drug discovery and the pharmaceutical sector. They also had the chance to immerse themselves in the vibrant culture of Barcelona, making this event an unforgettable experience. ✨ #WorldVaccineCongress #QS21 #VaccineAdjuvants #DesertKing #SustainableVaccines #Quillaja

🌟 Exciting Collaboration Announcement🌟 At Desert King we are thrilled about the opportunities that our collaboration with Vaccine Formulation Institute will bring. This partnership aims to harness the proven immunostimulant properties of Quillay saponins, making them accessible to millions around the globe. We are committed to responsible sourcing of this valuable raw material, and with Desert King's leadership in plantation development, we are poised to make a significant impact. Together, we are paving the way for innovative solutions that prioritize both health and sustainability. Stay tuned for more updates on this journey! 🌱✨ #DesertKing #VFI #Quillaja #Saponins #QS-21 #Collaboration #Adjuvants #Vaccines #Sustainability

🌍 Day 3 at the World Vaccine Congress Europe 2024 in Barcelona 🌍 Today, on the final day of the World Vaccine Congress, we closed our participation on a high note as event sponsors. Rodrigo Otero , Vice President of Desert King, presented to vaccine experts eager to learn more about QS-21: The Source of Saponin Adjuvants – Approved, Available, Abundant. Rodrigo emphasized that Desert King is the proven supplier of Quillaja Saponins and the only company capable of supplying large, ready-to-ship GMP+ volumes, with 1 kg of GMP+ grade QS-21 already available. He also noted that Desert King's QS-21 sets the quality benchmark as a human vaccine adjuvant, already used in five approved vaccines worldwide. As a result, Desert King’s saponin adjuvants are already in millions of arms globally. Another key highlight was Desert King’s holistic approach to Quillaja stewardship and our pioneering plantations, ensuring the uninterrupted availability of this vital resource. Thank you to everyone who attended the presentation and connected with the Desert King team throughout the congress. We are thrilled by the growing interest in QS-21 and all the opportunities and advantages it brings. We look forward to the next congress! Feel free to reach out directly if you have questions or would like more information: www.desertking.com. #WorldVaccineCongress #QS21 #DesertKing #VaccineInnovation #Sustainability #GlobalHealth

🌍 Day 2 at the World Vaccine Congress Europe 2024 in Barcelona 🌍 The Desert King team, with Rodrigo Otero, Zoltan Beck and Karen Cresp had the pleasure of connecting with vaccine experts from around the world, discussing the opportunities and advantages of using QS-21 as a vaccine adjuvant. Rodrigo highlighted the importance of dispelling myths surrounding QS-21: "QS-21 is a sustainable product. Desert King’s strict FSC practices and forest rotations ensure sustainable bark harvest. Additionally, hundreds of hectares of Quillaja plantations guarantee future bark availability, and new developments in QS-21 from clonal plantations will reduce or eliminate the need for bark harvest.” Visit us at booth 103A to learn more about our sustainable practices. We’re excited to share how QS-21 can be part of a sustainable future for global health! #WorldVaccineCongress #QS21 #DesertKing #Sustainability #GlobalHealth #Innovation

📍 Join Rodrigo Otero’s Presentation on QS-21 at the World Vaccine Congress Europe 2024 We are pleased to invite you to an exclusive presentation by Rodrigo Otero, V.P. of Desert King, at The World Vaccine Congress. Rodrigo will present "The Source of Saponin Adjuvants: QS-21 Approved, Available, and Abundant" on October 31, 2024, at 9:30 AM. This insightful session will explore the sustainable sourcing and production of QS-21, a powerful saponin-based adjuvant essential for enhancing vaccine efficacy. Rodrigo will discuss how Desert King ensures a consistent, reliable supply of QS-21 through innovative Quillaja saponaria stewardship, meeting growing global demands responsibly and sustainably. Presentation Details: 📅 Date: October 31, 2024 🕚 Time: 9:30 AM 📍 Location: Theatre 6, "Supply and Logistics", Fira de Barcelona Montjuïc Join us for a unique opportunity to delve into the future of vaccine adjuvants with Desert King. Don’t miss Rodrigo’s presentation to gain valuable insights into the role of QS-21 in advancing global health. #WorldVaccineCongress #QS21 #VaccineAdjuvants #DesertKing

🌍 Day 1 at The World Vaccine Congress Europe 2024! 🌍 We’re thrilled to kick off this exciting event in Barcelona, where Desert King is connecting with global leaders in the pharmaceutical industry. Yesterday, our Vicepresident, Rodrigo Otero, joined a dynamic panel on Saponin Adjuvants: Challenges and Opportunities. Rodrigo addressed a key myth surrounding QS-21: “The fear of a raw material shortage is unfounded. QS-21, the source of saponin adjuvants, is approved, available, and abundant. With sustainable Quillaja bark supplies estimated at 600 tons annually, we’re looking at the potential for 8 billion doses each year.” 🌿💉 We’re proud to support sustainable, scalable solutions that meet today’s global health needs. Visit us at Booth 103A and don’t miss Rodrigo’s talk on Thursday at 9:30 AM in Theatre 6 to dive deeper into QS-21’s potential! #WorldVaccineCongress #DesertKing #SustainableSolutions #QS21 #PharmaceuticalInnovation #GlobalHealth

We are excited to announce that Desert King will be participating in the The World Vaccine Congress Europe 2024, from October 29-31, 2024, in Barcelona, Spain. This premier event brings together key players from the vaccine industry to discuss the latest developments and innovations. We're also proud to announce that Rodrigo Otero will be presenting on "The Source of Saponin Adjuvants: QS-21 Approved, Available, and Abundant" on October 31, 2024, at 9:00 AM in “Supply & Logistics” (Theatre 6). His talk will highlight the sustainable sourcing and production of QS-21, an essential adjuvant in vaccine efficacy, and Desert King's commitment to a reliable supply chain. We warmly invite you to visit our booth and attend Rodrigo's presentation to learn more about how Desert King is shaping the future of vaccines through Quillaja saponaria stewardship and innovation. Event Details: 📅 Dates: October 29-31, 2024 📍 Location: Fira de Barcelona Montjuïc 🎤 Presentation: "The Source of Saponin Adjuvants: QS-21 Approved, Available, and Abundant" by Rodrigo Otero 🗓️ Date & Time: October 31, 2024, at 9:00 AM 🏢 Desert King Booth: 103A We look forward to seeing you there! #WorldVaccineCongress #QS21 #VaccineAdjuvants #DesertKing #SustainableVaccines #Quillaja